The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure

August 26, 2020 updated by: Elliott Boake, University of British Columbia
With exposure to high altitude some individuals will develop acute mountain sickness (AMS). Current evaluation of AMS can make it difficult to rule out other possible conditions. Evaluation of ataxia, as measured by the performance of a coordinated task, can aide in the correct diagnosis of AMS. The investigators have developed novel finger-tapping tasks on a mobile device to assess both reaction time and accuracy. The proposed research will evaluate the utility of this tool in assessing human acclimatization to hypoxia.

Study Overview

Detailed Description

Introduction: Hypoxia is the reduction in partial pressure of oxygen that occurs with exposure to altitude. Individuals acclimatize at different rates and to different degrees meaning that those who are slow to make the necessary physiological adjustments will develop signs and symptoms of acute mountain sickness (AMS). AMS is marked by headache, gastrointestinal disturbances, insomnia, fatigue and ataxia, which can be evaluated using subjective questionnaires such as the Lake Louise Score (LLS). Evaluation of AMS by solely using subjective questionnaires can make differential diagnosis of other possible pathologies difficult. Ataxia is characterized by poor coordination in the absence of significant weakness. Ataxia can be assessed with the performance of a coordinated task. The investigators have developed a novel finger-tapping task on a mobile device to assess both reaction time and accuracy. The proposed research will evaluate the utility of this tool in assessing human acclimatization to hypoxia, which could ultimately serve as a novel, objective methodology in the diagnosis of AMS.

Hypothesis: (1) When exposed to simulated altitude (equivalent to 4200m above sea level), subjects will exhibit diminished coordination relative to a sham exposure. (2) Reaction time of novel coordination tasks will positively correlate with heart rate, balance, and LLS. (3) Accuracy of novel coordination tasks will negatively correlate with heart rate, balance, and LLS.

Methods: A repeated-measures design with a familiarization trial, a hypoxic trial, and a sham trial will be used. Sixteen healthy adults will be exposed to normobaric hypoxia in the investigator's chamber, simulating an elevation of 4200m above sea level. Subjects will be measured for pulse oxygen saturation, heart rate, and will complete the LLS, the Balance Error Scoring System (BESS), as well as two electronic finger tap coordination tasks prior to, and at 5 minutes, 4, and 12 hours into the altitude chamber exposure.

Outcomes: This research will enhance the investigators understanding of the relationship between coordination, balance, and acclimatization to hypoxia. It will allow us to validate a new objective tool in the measurement of acclimatization with exposure to hypoxia.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada
        • Environmental Physiology Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both Male and Female Gender
  • Minimum Age of 18 years
  • Maximum Age of 45 years
  • Have not traveled to an altitude of 3000m or higher in 3 months prior to testing
  • No history of migraines or concussion
  • Not Smokers
  • Females must be using monophasic birth control
  • Not easily claustrophobic
  • English Speaking

Exclusion Criteria:

  • Non-English speaking individuals
  • Subjects younger than 18 years old or older than 45 years old
  • Subjects who visit an altitude of 3000m or greater within three months prior to the study
  • Subjects with a history of cardiovascular or pulmonary conditions such as; uncontrolled congestive heart failure, COPD, pulmonary hypertension, or sickle cell disease
  • Subjects with a history of migraines or concussion
  • Smokers
  • Females not using monophasic birth control pills
  • Subjects experiencing withdrawal symptoms due to abstinence from caffeine
  • Easily claustrophobic individuals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Moderate Hypoxia
Subjects will be exposed to moderate hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
Sham Comparator: Sham
Subjects will be exposed to sham and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
Active Comparator: Mild Hypoxia
Subjects will be exposed to mild hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in score of a coordination test.
Time Frame: Coordination test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Coordination test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in severity of symptoms based on questionnaire.
Time Frame: Symptoms questionnaire will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Symptoms questionnaire will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in score of a balance test.
Time Frame: Balance test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Balance test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in heart rate.
Time Frame: Heart rate will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Heart rate will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in pulse oxygen saturation
Time Frame: Pulse oxygen saturation will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Pulse oxygen saturation will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael S Koehle, MD, University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

November 3, 2015

First Submitted That Met QC Criteria

November 5, 2015

First Posted (Estimate)

November 9, 2015

Study Record Updates

Last Update Posted (Actual)

August 28, 2020

Last Update Submitted That Met QC Criteria

August 26, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • H15-02093

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoxia

Clinical Trials on AMS Monitor App

Subscribe